TARGETED DELIVERY OF CYTOTOXIC DRUGS A) TO ACTIVATED LYMPHOCYTES IN PATIENTS WITH TRANSPLANTED ORGANS, B) AS RADIOSENSITIZERS TO CANCER CELLS IN PATIENTS UNDERGOING RADIATION THERAPY, AND C) IN VITAMIN-BINDING PROTEINS AS DRUG CARRIERS IN THE DIAGNOSIS AND TREATMENT OF CANCER

摘要

This invention relates to the targeted delivery of cytotoxic drugs: A) to lymphocytes responsible for the rejection of transplanted tissues, such as kidneys or hearts or bone marrow cells; B) the use of a non-toxic naturally existing delivery system to transport high concentrations of radiosensitizers to cancer cells; and C) to the targeted delivery of drugs in medical diagnosis and treatment of cancer.